CME Financials
| CME Stock | USD 263.58 4.90 1.89% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.088 | 0.1294 |
|
| |||||
| Current Ratio | 1.22 | 1.007 |
|
|
Investors should never underestimate CME's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor CME's cash flow, debt, and profitability to make informed and accurate decisions about investing in CME Group.
Net Income |
|
CME | Select Account or Indicator |
Understanding current and past CME Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CME's financial statements are interrelated, with each one affecting the others. For example, an increase in CME's assets may result in an increase in income on the income statement.
Please note, the presentation of CME's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CME's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CME's management manipulating its earnings.
CME Stock Summary
CME competes with Nasdaq, SP Global, Moodys, MSCI, and Intercontinental. CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. It employs 3480 people.Specialization | Financial Services, Financial Data & Stock Exchanges |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US12572Q1058 |
| CUSIP | 12572Q105 167760107 |
| Location | Illinois; U.S.A |
| Business Address | 20 South Wacker |
| Sector | Capital Markets |
| Industry | Financials |
| Benchmark | Dow Jones Industrial |
| Website | www.cmegroup.com |
| Phone | 312 930 1000 |
| Currency | USD - US Dollar |
CME Key Financial Ratios
| Return On Equity | 0.13 | ||||
| Profit Margin | 0.58 % | ||||
| Operating Margin | 0.63 % | ||||
| Price To Sales | 15.18 X | ||||
| Revenue | 6.13 B |
CME Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 124.7B | 196.8B | 174.2B | 129.7B | 137.4B | 144.3B | |
| Other Current Liab | 88.1B | 159.6B | 137.5B | 93.3B | 101.5B | 106.6B | |
| Other Liab | 6.2B | 6.7B | 6.3B | 5.7B | 6.6B | 6.2B | |
| Net Debt | 1.8B | 610.2M | 718.3M | 971.9M | 535.6M | 833.6M | |
| Retained Earnings | 5.0B | 5.2B | 4.7B | 4.5B | 4.2B | 3.1B | |
| Accounts Payable | 69.3M | 48.8M | 121.4M | 90.6M | 79.9M | 53.2M | |
| Cash | 1.6B | 2.8B | 2.7B | 2.9B | 2.9B | 3.0B | |
| Other Assets | 7.3B | 3.3B | 574M | 134.4M | 154.6M | 146.8M | |
| Long Term Debt | 3.4B | 2.7B | 3.4B | 3.4B | 2.7B | 2.5B | |
| Net Receivables | 461.3M | 434.5M | 483.2M | 535.6M | 573.1M | 321.2M | |
| Other Current Assets | 302M | 158.4B | 135.8B | 91.3B | 99.5B | 104.4B | |
| Total Liab | 98.3B | 169.4B | 147.3B | 103.0B | 111.0B | 116.5B | |
| Total Current Assets | 89.3B | 161.8B | 139.1B | 94.9B | 103.0B | 108.2B | |
| Inventory | 86.8B | 158.0B | 135.3B | 94.9B | 109.1B | 114.6B | |
| Short Term Debt | 52.2M | 749.4M | 74.1M | 55.1M | 749.8M | 712.3M | |
| Intangible Assets | 22.0B | 20.7B | 20.4B | 20.2B | 17.2B | 18.4B | |
| Good Will | 10.8B | 10.5B | 10.5B | 10.5B | 10.5B | 9.0B | |
| Net Tangible Assets | (6.9B) | (6.5B) | (3.8B) | (4.0B) | (4.7B) | (4.9B) | |
| Long Term Debt Total | 3.8B | 3.7B | 3.4B | 2.7B | 3.1B | 2.9B |
CME Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 166.2M | 166.9M | 162.7M | 159.4M | 160.9M | 110.5M | |
| Total Revenue | 4.9B | 4.7B | 5.0B | 5.6B | 6.1B | 3.2B | |
| Gross Profit | 4.0B | 3.9B | 4.3B | 4.8B | 5.3B | 2.7B | |
| Operating Income | 2.6B | 2.6B | 3.0B | 3.4B | 3.9B | 4.1B | |
| Ebit | 891.6M | 945.4M | 1.4B | 3.4B | 4.7B | 4.9B | |
| Ebitda | 3.1B | 3.0B | 3.4B | 3.8B | 5.0B | 5.3B | |
| Income Before Tax | 2.7B | 3.4B | 3.5B | 4.2B | 4.5B | 4.8B | |
| Net Income | 2.1B | 2.6B | 2.7B | 3.2B | 3.5B | 3.7B | |
| Income Tax Expense | 615.7M | 736.7M | 799.3M | 927.4M | 1.0B | 1.1B | |
| Cost Of Revenue | 856.5M | 837M | 753.1M | 828.6M | 850.3M | 563.8M | |
| Research Development | 198.5M | 192.6M | 188.6M | 218.7M | 251.5M | 264.1M | |
| Tax Provision | 615.7M | 736.7M | 799.3M | 925.4M | 1.0B | 594.7M | |
| Net Interest Income | (166.2M) | (166.9M) | (162.7M) | (159.6M) | (160.9M) | (168.9M) |
CME Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 81.9M | 72.4B | (22.8B) | (44.9B) | 8.7B | 9.1B | |
| Free Cash Flow | 2.5B | 2.3B | 3.0B | 3.4B | 3.7B | 3.9B | |
| Depreciation | 464.4M | 385.4M | 362.6M | 352.6M | 221.7M | 238.5M | |
| Capital Expenditures | 197.5M | 127.2M | 89.7M | 76.4M | 94M | 126.9M | |
| Net Income | 2.1B | 2.6B | 2.7B | 3.2B | 3.5B | 3.7B | |
| End Period Cash Flow | 1.6B | 160.8B | 138.0B | 93.1B | 101.8B | 106.9B | |
| Dividends Paid | 2.1B | 2.2B | 2.6B | 3.2B | 3.6B | 3.8B | |
| Change To Netincome | 118.3M | 85.6M | (458.1M) | 97.6M | 87.8M | 92.2M | |
| Investments | (4.3M) | 98.5M | (489.8M) | 15.6M | (82.6M) | (78.5M) | |
| Change Receivables | (65.5M) | 60.8M | 28.2M | (45.7M) | (52.6M) | (49.9M) | |
| Net Borrowings | (661.7M) | (304.6M) | 71.2B | (22.7B) | (26.1B) | (24.8B) |
CME Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CME's current stock value. Our valuation model uses many indicators to compare CME value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CME competition to find correlations between indicators driving CME's intrinsic value. More Info.CME Group is rated third in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.14 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CME Group is roughly 7.20 . At present, CME's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value CME by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.CME Group Systematic Risk
CME's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CME volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on CME Group correlated with the market. If Beta is less than 0 CME generally moves in the opposite direction as compared to the market. If CME Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CME Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CME is generally in the same direction as the market. If Beta > 1 CME moves generally in the same direction as, but more than the movement of the benchmark.
CME Thematic Clasifications
CME Group is part of Blockchain investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Cross-industry collection of firms that are adopting blockchain technology. Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency
This theme covers Cross-industry collection of firms that are adopting blockchain technology. Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. Get More Thematic Ideas
| Blockchain | View |
Today, most investors in CME Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CME's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CME growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
CME March 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CME help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CME Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of CME Group based on widely used predictive technical indicators. In general, we focus on analyzing CME Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CME's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.14 | |||
| Information Ratio | 0.2507 | |||
| Maximum Drawdown | 4.9 | |||
| Value At Risk | (1.85) | |||
| Potential Upside | 1.75 |
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |